The lifelong natural history of clonal hematopoiesis and its links to myeloid malignancy.

The study of somatic mutations and the associated clonal mosaicism across the human body has transformed our understanding of ageing and its links to cancer. In proliferative human tissues, stem cells compete for dominance and those with an advantage expand clonally in relation to their peers. In the hematopoietic system, such expansion is termed clonal hematopoiesis (CH). The forces driving competition, namely heterogeneity of the hematopoietic stem cell (HSC) pool and attrition of the HSC environment, become increasingly prominent with age. As a result, CH becomes progressively more common through life, to the point of becoming essentially ubiquitous. We are beginning to unravel the specific intra- and extra-cellular factors underpinning clonal behavior, with somatic mutations in specific driver genes, inflammation, telomere maintenance, extraneous exposures and inherited genetic variation among the important players. The inevitability of CH with age, combined with its unequivocal links to myeloid cancers, poses a scientific and clinical challenge. Specifically, we need to decipher the factors determining clonal behavior and to develop prognostic tools to identify those at high risk of malignant progression, for whom preventive interventions may be warranted. Here, we discuss how recent advances in our understanding of the natural history of CH have provided important insights into these processes and helped define future avenues of investigation.

Informations de copyright

Copyright © 2023 American Society of Hematology.